# Efficacy and Safety of Intralesional 5-Fluorouracil and Triamcinolone Acetonide in Keloids and Hypertrophic Scars

> **NCT07034482** · — · COMPLETED · sponsor: **Maharajgunj Medical Campus** · enrollment: 41 (actual)

## Conditions studied

- Keloids

## Interventions

- **DRUG:** Intralesional Triamcinolone 5 mg/ml
- **DRUG:** Intralesional 5-fluorouracil

## Key facts

- **NCT ID:** NCT07034482
- **Lead sponsor:** Maharajgunj Medical Campus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07034482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07034482, "Efficacy and Safety of Intralesional 5-Fluorouracil and Triamcinolone Acetonide in Keloids and Hypertrophic Scars". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07034482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*